Loading...

LCTX LINEAGE CELL THERAPEUTICS INC Other Situations 8-K Filing

LNG

LCTX

LINEAGE CELL THERAPEUTICS INC

(LCTX)

2023 8-K

Show Summary

Show Summary

Product Expansion

Appointing New Auditor

Financial Statements

Product Expansion

Financial Results

Shareholder Approval

Securities Offering

Financial Results

Earnings Reports

Change of Auditor

Bylaws Amendment and Annual...

Earnings Reports

Sales Agreement

Earnings Reports

Announcement of Annual Meeting

Stock Purchase Agreement

Earnings Reports

Earnings Reports

Announcement of Annual Meeting

Opinion on Common Share Iss...

Earnings Reports

External Links:

Lineage Cell Therapeutics, Inc. issued an opinion from Sheppard, Mullin, Richter & Hampton LLP regarding the legality of the issuance and sale of common shares.

AI Assistant

LINEAGE CELL THERAPEUTICS INC

2023

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.